N-docosahexaenoylethanolamide promotes development of hippocampal neurons

Hee Yong Kim, Hyun-Seuk Moon, Dehua Cao, Jeongrim Lee, Karl Kevala, Sang Beom Jun, David M. Lovinger, Mohammed Akbar, Bill X. Huang

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

DHA (docosahexaenoic acid, C22:6,n-3) has been shown to promote neurite growth and synaptogenesis in embryonic hippocampal neurons, supporting the importance of DHA known for hippocampus-related learning and memory function. In the present study, we demonstrate that DHA metabolism to DEA (N-docosahexaenoylethanolamide) is a significant mechanism for hippocampal neuronal development, contributing to synaptic function. We found that a fatty acid amide hydrolase inhibitor URB597 potentiates DHA-induced neurite growth, synaptogenesis and synaptic protein expression. Active metabolism of DHA to DEA was observed in embryonic day 18 hippocampal neuronal cultures, which was increased further by URB597. Synthetic DEA promoted hippocampal neurite growth and synaptogenesis at substantially lower concentrations in comparison with DHA. DEA-treated neurons increased the expression of synapsins and glutamate receptor subunits and exhibited enhanced glutamatergic synaptic activity, as was the case for DHA. The DEA level in mouse fetal hippocampi was altered according to the maternal dietary supply of n-3 fatty acids, suggesting that DEA formation is a relevant in vivo process responding to the DHA status. In conclusion, DHA metabolism to DEA is a significant biochemical mechanism for neurite growth, synaptogenesis and synaptic protein expression, leading to enhanced glutamatergic synaptic function. The novel DEA-dependent mechanism offers a new molecular insight into hippocampal neurodevelopment and function.

Original languageEnglish
Pages (from-to)327-336
Number of pages10
JournalBiochemical Journal
Volume435
Issue number2
DOIs
Publication statusPublished - 2011 Apr 15
Externally publishedYes

Fingerprint

Neurons
Neurites
Metabolism
Growth
Hippocampus
Synapsins
N-docosahexaenoylethanolamide
Docosahexaenoic Acids
Omega-3 Fatty Acids
Glutamate Receptors
Proteins
Mothers
Learning
Data storage equipment

Keywords

  • Docosahexaenoic acid (DHA)
  • Hippocampus
  • N-docosahexaenoylethanolamide (DEA)
  • Neurite growth
  • Neuron
  • Synaptogenesis

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Kim, H. Y., Moon, H-S., Cao, D., Lee, J., Kevala, K., Jun, S. B., ... Huang, B. X. (2011). N-docosahexaenoylethanolamide promotes development of hippocampal neurons. Biochemical Journal, 435(2), 327-336. https://doi.org/10.1042/BJ20102118

N-docosahexaenoylethanolamide promotes development of hippocampal neurons. / Kim, Hee Yong; Moon, Hyun-Seuk; Cao, Dehua; Lee, Jeongrim; Kevala, Karl; Jun, Sang Beom; Lovinger, David M.; Akbar, Mohammed; Huang, Bill X.

In: Biochemical Journal, Vol. 435, No. 2, 15.04.2011, p. 327-336.

Research output: Contribution to journalArticle

Kim, HY, Moon, H-S, Cao, D, Lee, J, Kevala, K, Jun, SB, Lovinger, DM, Akbar, M & Huang, BX 2011, 'N-docosahexaenoylethanolamide promotes development of hippocampal neurons', Biochemical Journal, vol. 435, no. 2, pp. 327-336. https://doi.org/10.1042/BJ20102118
Kim, Hee Yong ; Moon, Hyun-Seuk ; Cao, Dehua ; Lee, Jeongrim ; Kevala, Karl ; Jun, Sang Beom ; Lovinger, David M. ; Akbar, Mohammed ; Huang, Bill X. / N-docosahexaenoylethanolamide promotes development of hippocampal neurons. In: Biochemical Journal. 2011 ; Vol. 435, No. 2. pp. 327-336.
@article{da28d53fcec24a7fba6a39892a4f868d,
title = "N-docosahexaenoylethanolamide promotes development of hippocampal neurons",
abstract = "DHA (docosahexaenoic acid, C22:6,n-3) has been shown to promote neurite growth and synaptogenesis in embryonic hippocampal neurons, supporting the importance of DHA known for hippocampus-related learning and memory function. In the present study, we demonstrate that DHA metabolism to DEA (N-docosahexaenoylethanolamide) is a significant mechanism for hippocampal neuronal development, contributing to synaptic function. We found that a fatty acid amide hydrolase inhibitor URB597 potentiates DHA-induced neurite growth, synaptogenesis and synaptic protein expression. Active metabolism of DHA to DEA was observed in embryonic day 18 hippocampal neuronal cultures, which was increased further by URB597. Synthetic DEA promoted hippocampal neurite growth and synaptogenesis at substantially lower concentrations in comparison with DHA. DEA-treated neurons increased the expression of synapsins and glutamate receptor subunits and exhibited enhanced glutamatergic synaptic activity, as was the case for DHA. The DEA level in mouse fetal hippocampi was altered according to the maternal dietary supply of n-3 fatty acids, suggesting that DEA formation is a relevant in vivo process responding to the DHA status. In conclusion, DHA metabolism to DEA is a significant biochemical mechanism for neurite growth, synaptogenesis and synaptic protein expression, leading to enhanced glutamatergic synaptic function. The novel DEA-dependent mechanism offers a new molecular insight into hippocampal neurodevelopment and function.",
keywords = "Docosahexaenoic acid (DHA), Hippocampus, N-docosahexaenoylethanolamide (DEA), Neurite growth, Neuron, Synaptogenesis",
author = "Kim, {Hee Yong} and Hyun-Seuk Moon and Dehua Cao and Jeongrim Lee and Karl Kevala and Jun, {Sang Beom} and Lovinger, {David M.} and Mohammed Akbar and Huang, {Bill X.}",
year = "2011",
month = "4",
day = "15",
doi = "10.1042/BJ20102118",
language = "English",
volume = "435",
pages = "327--336",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - N-docosahexaenoylethanolamide promotes development of hippocampal neurons

AU - Kim, Hee Yong

AU - Moon, Hyun-Seuk

AU - Cao, Dehua

AU - Lee, Jeongrim

AU - Kevala, Karl

AU - Jun, Sang Beom

AU - Lovinger, David M.

AU - Akbar, Mohammed

AU - Huang, Bill X.

PY - 2011/4/15

Y1 - 2011/4/15

N2 - DHA (docosahexaenoic acid, C22:6,n-3) has been shown to promote neurite growth and synaptogenesis in embryonic hippocampal neurons, supporting the importance of DHA known for hippocampus-related learning and memory function. In the present study, we demonstrate that DHA metabolism to DEA (N-docosahexaenoylethanolamide) is a significant mechanism for hippocampal neuronal development, contributing to synaptic function. We found that a fatty acid amide hydrolase inhibitor URB597 potentiates DHA-induced neurite growth, synaptogenesis and synaptic protein expression. Active metabolism of DHA to DEA was observed in embryonic day 18 hippocampal neuronal cultures, which was increased further by URB597. Synthetic DEA promoted hippocampal neurite growth and synaptogenesis at substantially lower concentrations in comparison with DHA. DEA-treated neurons increased the expression of synapsins and glutamate receptor subunits and exhibited enhanced glutamatergic synaptic activity, as was the case for DHA. The DEA level in mouse fetal hippocampi was altered according to the maternal dietary supply of n-3 fatty acids, suggesting that DEA formation is a relevant in vivo process responding to the DHA status. In conclusion, DHA metabolism to DEA is a significant biochemical mechanism for neurite growth, synaptogenesis and synaptic protein expression, leading to enhanced glutamatergic synaptic function. The novel DEA-dependent mechanism offers a new molecular insight into hippocampal neurodevelopment and function.

AB - DHA (docosahexaenoic acid, C22:6,n-3) has been shown to promote neurite growth and synaptogenesis in embryonic hippocampal neurons, supporting the importance of DHA known for hippocampus-related learning and memory function. In the present study, we demonstrate that DHA metabolism to DEA (N-docosahexaenoylethanolamide) is a significant mechanism for hippocampal neuronal development, contributing to synaptic function. We found that a fatty acid amide hydrolase inhibitor URB597 potentiates DHA-induced neurite growth, synaptogenesis and synaptic protein expression. Active metabolism of DHA to DEA was observed in embryonic day 18 hippocampal neuronal cultures, which was increased further by URB597. Synthetic DEA promoted hippocampal neurite growth and synaptogenesis at substantially lower concentrations in comparison with DHA. DEA-treated neurons increased the expression of synapsins and glutamate receptor subunits and exhibited enhanced glutamatergic synaptic activity, as was the case for DHA. The DEA level in mouse fetal hippocampi was altered according to the maternal dietary supply of n-3 fatty acids, suggesting that DEA formation is a relevant in vivo process responding to the DHA status. In conclusion, DHA metabolism to DEA is a significant biochemical mechanism for neurite growth, synaptogenesis and synaptic protein expression, leading to enhanced glutamatergic synaptic function. The novel DEA-dependent mechanism offers a new molecular insight into hippocampal neurodevelopment and function.

KW - Docosahexaenoic acid (DHA)

KW - Hippocampus

KW - N-docosahexaenoylethanolamide (DEA)

KW - Neurite growth

KW - Neuron

KW - Synaptogenesis

UR - http://www.scopus.com/inward/record.url?scp=79953173933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953173933&partnerID=8YFLogxK

U2 - 10.1042/BJ20102118

DO - 10.1042/BJ20102118

M3 - Article

C2 - 21281269

AN - SCOPUS:79953173933

VL - 435

SP - 327

EP - 336

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -